SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation
CRSP 61.12-2.3%3:59 PM EDT
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: kenhott who wrote (32865)11/11/2009 12:46:54 PM
From: Biomaven  Read Replies (3) of 52153
 
So say you sell the 2012 $100 calls - big spread, but maybe you could get near $4.50 for them. If the deal fails because of regulatory/finance risks, I think you are good, as BNI should go down. If Berkshire stock soars above the collar, then I think the way the deal works is that more people will elect shares and the option holders will be stuck with $100 cash. (Have to check that is actually the case).

So the only real risk if the above analysis is correct is that someone else steps in with a competing offer. That seems pretty remote to me.

Thoughts?

Peter
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News